A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO
Squawk Pod16 Kesä 2020

A Potential Covid Breakthrough; CNBC Disruptors: Stripe CEO

An Oxford University trial revealed that Dexamethasone, a common and inexpensive steroid, has been shown to improve survival rates in some Covid-19 patients. CNBC’s Meg Tirrell and Former FDA Commissioner Dr. Scott Gottlieb discuss the significance of this finding and its impact on health workers, global hope, and U.S. markets. CNBC has unveiled its annual list of Disruptors, a group of 50 up-and-coming companies disrupting industries and legacy brands. Number one on the list: payment platform Stripe. CEO John Collison shares how his platform’s been helping businesses stay afloat throughout the pandemic, and how he plans to keep his own business growing.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaksot(1762)

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
psykopodiaa-podcast
mimmit-sijoittaa
rss-rahapodi
kasvun-kipuja
pomojen-suusta
rss-myynti-ei-ole-kirosana
rss-ainin-sekatoimisto
taloudellinen-mielenrauha
ostan-asuntoja-podcast
pari-sanaa-lastensuojelusta
rss-neuvottelija-sami-miettinen
lakicast
rss-lahtijat
rss-startup-ministerio
rss-seuraava-potilas
rss-rahamania
raharesepti
rss-kaupan-tila
rss-moraaliton-podcast